Ogbuanu Ikechukwu U, Muroua Clementine, Allies Martiena, Chitala Kennedy, Gerber Sue, Shilunga Primus, Mhata Petrus, Kriss Jennifer L, Caparos Lucille, Smit Sheilagh B, De Wee Roselina J, Goodson James L
Global Immunization Division, Center for Global Health, US Centers for Disease Control and Prevention, Atlanta, USA; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
S Afr Med J. 2016 Jun 17;106(7):715-20. doi: 10.7196/SAMJ.2016.v106i7.10651.
The World Health Organization, African Region, set the goal of achieving measles elimination by 2020. Namibia was one of seven African countries to implement an accelerated measles control strategy beginning in 1996. Following implementation of this strategy, measles incidence decreased; however, between 2009 and 2011 a major outbreak occurred in Namibia.
Measles vaccination coverage data were analysed and a descriptive epidemiological analysis of the measles outbreak was conducted using measles case-based surveillance and laboratory data.
During 1989 - 2008, MCV1 (the first routine dose of measles vaccine) coverage increased from 56% to 73% and five supplementary immunisation activities were implemented. During the outbreak (August 2009 - February 2011), 4 605 suspected measles cases were reported; of these, 3 256 were confirmed by laboratory testing or epidemiological linkage. Opuwo, a largely rural district in north-western Namibia with nomadic populations, had the highest confirmed measles incidence (16 427 cases per million). Infants aged ≤11 months had the highest cumulative age-specific incidence (9 252 cases per million) and comprised 22% of all confirmed cases; however, cases occurred across a wide age range, including adults aged ≥30 years. Among confirmed cases, 85% were unvaccinated or had unknown vaccination history. The predominantly detected measles virus genotype was B3, circulating in concurrent outbreaks in southern Africa, and B2, previously detected in Angola.
A large-scale measles outbreak with sustained transmission over 18 months occurred in Namibia, probably caused by importation. The wide age distribution of cases indicated measles-susceptible individuals accumulated over several decades prior to the start of the outbreak.
世界卫生组织非洲区域设定了到2020年消除麻疹的目标。纳米比亚是从1996年开始实施加速麻疹控制策略的七个非洲国家之一。实施该策略后,麻疹发病率有所下降;然而,在2009年至2011年期间,纳米比亚发生了一次大规模疫情。
分析了麻疹疫苗接种覆盖率数据,并利用基于麻疹病例的监测和实验室数据对麻疹疫情进行了描述性流行病学分析。
在1989 - 2008年期间,第一剂常规麻疹疫苗(MCV1)的接种覆盖率从56%提高到73%,并开展了五次补充免疫活动。在疫情期间(2009年8月至2011年2月),报告了4605例疑似麻疹病例;其中,3256例通过实验室检测或流行病学关联得到确诊。奥普沃是纳米比亚西北部一个以游牧人口为主的农村地区,确诊麻疹发病率最高(每百万人口16427例)。年龄≤11个月的婴儿累计特定年龄发病率最高(每百万人口9252例),占所有确诊病例的22%;然而,病例发生在广泛的年龄范围内,包括30岁及以上的成年人。在确诊病例中,85%未接种疫苗或疫苗接种史不明。主要检测到的麻疹病毒基因型为B3,在南部非洲同时发生的疫情中传播,以及B2,此前在安哥拉检测到。
纳米比亚发生了一次持续18个月的大规模麻疹疫情,可能是由输入引起的。病例的广泛年龄分布表明,在疫情开始前的几十年里积累了大量对麻疹易感的个体。